Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-08-27

EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier

View source ↗

Summary

Voranigo (vorasidenib) from Les Laboratoires Servier has been authorised by the EMA for certain gliomas, including oligodendroglioma and astrocytoma, and has or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VORANIGO (VORASIDENIB)

Snippet

Status: Authorised. Therapeutic area: Oligodendroglioma;Astrocytoma. MAH: Les Laboratoires Servier. Decision date: 26/08/2026. Orphan medicine